ArticleBMC public health2025
Impact of COVID-19 pandemic on Legionella testing and infection rates in Ontario.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe disruption of healthcare systems during the COVID-19 pandemic had widespread effects on patient care, including interruption of scheduled visits and diagnostic testing. Many diseases were under-investigated due to the focus on the SARS-CoV-2 virus and the redeployment of resources to the pandemic response. This study aimed to assess Legionella trends in Ontario during the COVID-19 pandemic years, by comparing the demographics of individuals tested for Legionella prior to pandemic (2018 and 2019) to those during the pandemic (2020, 2021 and 2022). Additionally, for individuals who underwent Legionella testing, testing for additional respiratory pathogens was examined in the context of Legionella co-detection.
methodsTwo Poisson regression models were constructed to compare testing rate and positivity rate during the pre-pandemic years with the pandemic years, adjusted for age, sex, year, and Ontario population.
resultsRelative to the pre-pandemic years, the testing rates significantly decreased by 8% in 2020, decreased by 8% in 2021 and increased by 14% in 2022. The positivity rate for Legionella decreased by 13% only in 2020 but did not reach significance for the other two years. Individuals older than 50 years of age and males remained the population with highest positivity rate of Legionella infection across all years. Co-detection of Legionella with SARS-CoV-2 or seasonal respiratory viruses was rare but present during the pandemic.
conclusionsLegionella testing rates decreased by 8% in 2020 and 8% in 2021 and increased by 14% in 2022, which was associated with a decrease in positivity rate only in 2020, at 13%, but not in the other two years. Maintaining vigilance for Legionella testing in future pandemics may support timely diagnosis and treatment, leading to improved patient outcomes. Co-detection of Legionella with SARS-CoV-2 or seasonal respiratory viruses was rare but present during the pandemic. Accordingly, Legionella testing remains essential among high-risk groups, such as the elderly with co-morbidities, critically ill patients, or those with severe or unresponsive pneumonia. Such an approach can aid in differential diagnosis, prompt appropriate treatment, and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.